Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register
      S&P 500
      4,337.44
      (
      0.4%
      )
      US Tech 100
      14,386.40
      (
      0.49%
      )
      Dow Jones
      34,006.88
      (
      0.13%
      )
      Brent Oil
      91.715
      (
      -0.35%
      )
      Bitcoin
      26,356.09
      (
      0.23%
      )
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Theravance Biopharma Inc (TBPH)

      7. Theravance Biopharma Inc (TBPH) Quote

      TBPH Theravance Biopharma Inc

      9.37
      0.26 (2.85%)
      Sep 25 2023 - Closed
      Delayed by 15 minutes

      Register Free for Streaming Quotes & Tools

      Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

      Register

      Period:

      Draw Mode:

      Volume 592,854
      Bid Price 9.03
      Ask Price 9.40
      News -
      Day High 9.40

      Low
      8.755

      52 Week Range

      High
      12.03

      Day Low 9.01
      Company Name Stock Ticker Symbol Market Type
      Theravance Biopharma Inc TBPH NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.26 2.85% 9.37 17:19:38
      Open Price Low Price High Price Close Price Prev Close
      9.10 9.01 9.40 9.37 9.11
      Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
      7,158 592,854 $ 9.26 $ 5,487,627 - 8.755 - 12.03
      Last Trade Time Type Quantity Stock Price Currency
      16:07:44 1 $ 9.08 USD

      Theravance Biopharma Inc Financials
      Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
      494.86M 52.81M - 51.35M 872.13M 16.51 0.57
      Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
      - - - -

      more financials information »

      Theravance Biopharma News

      Loading Messages....

      {{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

      Loading Messages....
      No posts yet, be the first! No TBPH Message Board. Create One! See More Posts on TBPH Message Board See More Message Board Posts

      Historical TBPH Price Data
      Period Open High Low VWAP Avg. Daily Vol Change %
      1 Week9.019.408.7558.99435,3350.364.0%
      1 Month9.4510.188.7559.41530,412-0.08-0.85%
      3 Months10.3010.598.7559.66430,752-0.93-9.03%
      6 Months10.5612.038.75510.48513,834-1.19-11.27%
      1 Year9.9312.038.75510.50571,154-0.56-5.64%
      3 Years15.4722.746.1010.84681,377-6.10-39.43%
      5 Years29.1635.486.1013.55528,176-19.79-67.87%

      Theravance Biopharma Description

      Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).